Spectroscopic Studies of Quinobenzothiazine Derivative in Terms of the In Vitro Interaction with Selected Human Plasma Proteins: Part 2
Molecules · 2023
DOI: 10.3390/molecules28020698 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von Aleksandra Owczarzy und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physical Pharmacy, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, 40-055 Katowice, Poland. Hauptthemen laut MEDLINE: Serum Albumin, Serum Albumin, Human. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Silesia.
Abstract (Originalsprache)
Synthesis of anticancer substances and studying their binding abilities towards human serum proteins as carriers are important parts of pharmaceutical and medical sciences development. The presented work is a continuation of studies of quinobenzothiazine derivatives binding with serum proteins. The main aim of this work was a spectroscopic analysis of second from benzothiazinium derivatives salt, 9-fluoro-5-alkyl-12(H)-quino [3,4-b][1,4]benzothiazinium chloride (Salt2), its interaction with carrier proteins, i.e., human serum albumin (HSA), α1-acid glycoprotein (AGP), human gamma globulin (HGG), and the study of protein secondary and tertiary structure changes using spectroscopic techniques (spectrofluorescence, UV-Vis and circular dichroism CD spectroscopy). In order to mimic in vivo conditions, control normal serum (CNS) was used. Using the Klotz method, both binding constants (Ka [M−1]) and the number of binding classes (n) were calculated. In addition, the percentage of displacement of binding site markers from HSA and AGP molecules has been defined. Based on the obtained data, it can be concluded that the main binding protein for Salt2 is AGP. HSA and HGG are also involved in the distribution of the studied substance in the bloodstream. Moreover, Salt2 very slightly interacts with CNS, which can cause strong therapeutic as well as toxic effects. The analysis of CD spectra confirms that there are no changes in the secondary structure of the main binding proteins in the presence of Salt2.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physical Pharmacy, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, 40-055 Katowice, Poland.
- Department of Organic Chemistry, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, 40-055 Katowice, Poland.
ORCID-Profile: Andrzej Zięba, Małgorzata Maciążek-Jurczyk
Förderung
- Medical University of Silesia
Zitieren
APA
Owczarzy, A., Rogóż, W., Kulig, K., Pożycka, J., Zięba, A., & Maciążek-Jurczyk, M. (2023). Spectroscopic Studies of Quinobenzothiazine Derivative in Terms of the In Vitro Interaction with Selected Human Plasma Proteins: Part 2. Molecules. https://doi.org/10.3390/molecules28020698
Vancouver
Owczarzy A, Rogóż W, Kulig K, Pożycka J, Zięba A, Maciążek-Jurczyk M. Spectroscopic Studies of Quinobenzothiazine Derivative in Terms of the In Vitro Interaction with Selected Human Plasma Proteins: Part 2. Molecules. 2023. doi:10.3390/molecules28020698
BibTeX
@article{Owczarzy2023,
author = {Owczarzy, Aleksandra and Rogóż, Wojciech and Kulig, Karolina and Pożycka, Jadwiga and Zięba, Andrzej and Maciążek-Jurczyk, Małgorzata},
title = {Spectroscopic Studies of Quinobenzothiazine Derivative in Terms of the In Vitro Interaction with Selected Human Plasma Proteins: Part 2},
journal = {Molecules},
year = {2023},
doi = {10.3390/molecules28020698}
}
EUVIMED